Literature DB >> 3244644

Reply to "Assessment of Variance in Bioavailability Studies: comments on the article by McNamara et al." by Carl M. Metzler.

J P Skelly, V P Shah, D J Schuirmann.   

Abstract

Mesh：

Year:  1988        PMID： 3244644     DOI： 10.1023/a:1015991007536

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  4 in total

1.  Assessment of variance in bioavailability studies: comments on the article by McNamara et al.

Authors:  C M Metzler
Journal:  Pharm Res       Date:  1987-12       Impact factor: 4.200

2.  A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.

Authors:  D J Schuirmann
Journal:  J Pharmacokinet Biopharm       Date:  1987-12

3.  Statistical simulation study of new proposed uniformity requirement for bioequivalency studies.

Authors:  J D Haynes
Journal:  J Pharm Sci       Date:  1981-06       Impact factor: 3.534

4.  Influence of tablet dissolution on furosemide bioavailability: a bioequivalence study.

Authors:  P J McNamara; T S Foster; G A Digenis; R B Patel; W A Craig; P G Welling; R S Rapaka; V K Prasad; V P Shah
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200
  4 in total
  1 in total

Review 1.  Review of methods and criteria for the evaluation of bioequivalence studies.

Authors:  G Pabst; H Jaeger
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.